A28 RELATIVE RATES OF ULCERATIVE COLITIS TO CROHN’S DISEASE: PARALLEL EPIDEMIOLOGIES IN NEWLY VS. HIGHLY INDUSTRIALIZED COUNTRIES
Open accessAbstract
Background: Inflammatory bowel disease (IBD) first presents in a population as cases of ulcerative colitis (UC) followed by cases of Crohn’s disease (CD). Newly industrialized countries (NIC) show a prallel epidemiology of IBD to highly industrialized countries (HIC) in the previous century; one marker of this is the relative incidence/prevalence rates of UC to CD, which approximates 1 over time. Aims: Provide evidence for the UC:CD ratio as a proxy for disease penatrance in a population. Methods: Systematic review of MedLine and Embase for studies reporting incidence or prevalence of UC and CD. Log-linear regression (by region and NIC/HIC [2019 United Nations definitions]) was used to calculate average annual percent change (AAPC) and associated 95% confidence intervals (CI). Data were plotted on an online, interactive map to show trends (link provided). Results: We extracted data from 218 studies compising population-level data from 69 countries. We found negative AAPCs as the prevalence ratio of UC:CD significantly decreased over time in East Asia, West Asia, North Europe, and South Europe; 6/12 global regions displayed significantly decreasing incidence ratios. No AAPC was found to be significantly increasing (Table 1). When examing HIC/NIC, we found a significant effect of NIC on the UC:CD prevalence ratio after 2000 (AAPC:−3.83;95%CI:−6.28,−1.31) while HIC regions remained stable (AAPC:2.14;95%CI:−1.40,5.82). Looking at all available data, both HICs and NICs show significantly decreasing UC:CD prevalence ratios (HIC:AAPC:−3.72;95% CI:−4.46,−2.97; NIC:AAPC:−2.62;95%CI:−4.13,−1.08). Conclusions: In some HICs (eg. Canada), the UC:CD incidence ratio was <1 in the earliest available data (1966), explaining the stable AAPC in North America (AAPC:−0.24;95%CI:−1.12,0.65). However, in NICs (eg. Southern Asia), the AAPC is rapidly decreasing (AAPC:−24.68;95%CI:−37.85,−8.71) as areas like Sri Lanka rapidly fall from an incidence ratio of 7.5 (2007) to 2.8 (2012), mimicking trends in IBD epidimeology of HICs in the previous century. Funding Agencies: None
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The current Western-world Prevalence Doubling Period is probably 20-25 years.
“In the Western world, the Prevalence Doubling Period is currently likely to be 20–25 years; for example, in Olmsted County, MN, USA, the Prevalence Doubling Period was approximately 25 years from 145 per 100,000 in 1965 to 362 per 100,000 in 1991 (refs32,67,68).”
From The four epidemiological stages in the global evolution of inflammatory bowel disease (2021) · cites this paper as [77]
Cited by
Sorted by citations
The four epidemiological stages in the global evolution of inflammatory bowel disease
Kaplan, G. G., & Windsor, J. W. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00360-x · Cited by 1,351 · see citing works
Self-citation
- Authors
- Windsor, J. W., Buie, M., Coward, S., Gearry, R., Hansen, T., King, J. A., Kotze, P., Ma, C., Ng, S., Panaccione, N., Panaccione, R., Quan, J., Seow, C., Underwood, F., & Kaplan, G. G.
- Affiliations
- University of Calgary (CA)
- University of Otago (NZ)
- Pontifícia Universidade Católica do Paraná (BR)
- Chinese University of Hong Kong (HK)
- ORCID
- Venue
- Journal of the Canadian Association of Gastroenterology
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-02
- Volume
- 3
- Issue
- Supplement_1
- Pages
- 34-35
- ISSN
- 2515-2084 (ISSN-L)
- 2515-2092
- PMC
- PMC7043443
- OpenAlex
- W3008878173
- Cited by
- 3
- References
- 0
- Citations by year
- 2025: 1 · 2024: 1 · 2020: 1
- FWCI
- 0.15
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of the Canadian Association of Gastroenterology (publishedVersion)
- PubMed Central (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Keywords
- ulcerative colitis, Crohn's disease, inflammatory bowel disease, disease prevalence trends, newly industrializing countries, East Asia, North America, Europe, incidence trends
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review